Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
1 this month

Showing 6401–6420 of 17,529 recalls

October 1, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Ranitidine Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
October 1, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Ranitidine Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
October 1, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Ranitidine Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
October 1, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Dr. Reddy's Ranitidine Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
October 1, 2019· New Vitalis Pharmacy LLC dba New Vitalis Pharmacy

Recalled Item: Testosterone Cypionate 180 mg/mL/Testosterone Propionate 20mg/mL Oil...

The Issue: Lack of sterility assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 1, 2019· Sato Pharmaceutical Inc.

Recalled Item: Motion Sickness (meclizine hydrochloride) 25 mg tablets

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 1, 2019· Sato Pharmaceutical Inc.

Recalled Item: Zentrip (meclizine Hydrochloride)

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 1, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Ranitidine Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
October 1, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Ranitidine Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
October 1, 2019· Sato Pharmaceutical Inc.

Recalled Item: Motion Sickness Strips (meclizine hydrochloride) 25 mg strips

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 1, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Ranitidine Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
October 1, 2019· Sato Pharmaceutical Inc.

Recalled Item: WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 1, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Ranitidine Tablets 75 mg

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
October 1, 2019· Sato Pharmaceutical Inc.

Recalled Item: Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36

The Issue: Subpotent Drug: Formulated amount of sennosides component is

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 1, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Ranitidine Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
October 1, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Ranitidine Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
October 1, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Ranitidine Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
October 1, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Ranitidine Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
October 1, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Dr. Reddy's: Ranitidine Capsules 150 mg

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
October 1, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Dr. Reddy's Ranitidine Tablets

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund